icd 10 code for squamous cell carcinoma in situ

Refers to a mixed tumor containing both adenocarcinoma and squamous cell carcinoma, wherein each of these cell types comprise at least 10% of the tumor volume. required field. %PDF-1.5 % preparation of this material, or the analysis of information provided in the material. The views and/or positions presented in the material do not necessarily represent the views of the AHA. The Medicare program provides limited benefits for outpatient prescription drugs. Cutaneous SCC is an invasive disease, referring to cancer cells that have grown beyond the epidermis. The 2023 edition of ICD-10-CM D04.9 became effective on October 1, 2022. Copyright © 2022, the American Hospital Association, Chicago, Illinois. These rules can be found i n the front of the ICD-O-3 code book. (ajcc 6th and 7th eds.). A Draft article will eventually be replaced by a Billing and Coding article once the Proposed LCD is released to a final LCD. The AMA does not directly or indirectly practice medicine or dispense medical services. The CMS.gov Web site currently does not fully support browsers with Applications are available at the AMA Web site, http://www.ama-assn.org/go/cpt. Use of indoor UV tanning equipment increases a persons risk of developing squamous cell carcinoma by 67 percent. This treatment is often used for small or very superficial squamous cell cancers of the skin. Youll find a lot of suggestions and better answers to your question in the Member Forums. Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The codes for squamous cell carcinoma are under category C44 Other and unspecified malignant neoplasm of skin. Note: Squamous cell carcinoma of the perianal skin (C445) is : not : . The following ICD-10-CM codes support medical necessity and provide limited coverage for CPT codes: 11620, 11621, 11622, 11623, 11624, and 11626. The following ICD-10-CM codes support medical necessity and provide limited coverage for CPT codes: 17260, 17261, 17262, 17263, 17264, 17266, 17270, 17271, 17272, 17273, 17274, 17276, 17280, 17281, 17282, 17283, 17284, 17286. In this context, annotation back-references refer to codes that contain: This is the American ICD-10-CM version of. The Centers for Medicare & Medicaid Services (CMS), the federal agency responsible for administration of the Medicare, The AMA assumes no liability for data contained or not contained herein. Oncology. Contractors may specify Bill Types to help providers identify those Bill Types typically When verrucous carcinoma forms on your feet, they manage it as a skin cancer. A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. Refer to the LCD for reasonable and necessary requirements and limitations. CPT is provided "as is" without warranty of any kind, either expressed or implied, including but not limited to, the implied warranties of merchantability and fitness for a particular purpose. . Billing and Coding articles provide guidance for the related Local Coverage Determination (LCD) and assist providers in submitting correct claims for payment. ICD-10-CM Coding instruction note: Excludes familial polycythemia (C75.0), secondary polycythemia (D75.1) D46.- Myelodysplastic syndromes . In this context, annotation back-references refer to codes that contain: This is the American ICD-10-CM version of. squamous cell carcinoma in situ icd 10: Sometimes, a large group can make scrolling thru a document unwieldy. Complete absence of all Bill Types indicates An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. See note under "HIST" variable. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. Usual type vulval intraepithelial neoplasia Articles often contain coding or other guidelines that are related to a Local Coverage Determination (LCD). The CMS.gov Web site currently does not fully support browsers with Treatment can involve surgical and nonsurgical methods. If you are looking for a specific code, use your browser's Find function (Ctrl-F) to quickly locate the code in the article. Subject to the terms and conditions contained in this Agreement, you, your employees and agents are authorized to use CDT only as contained in the following authorized materials and solely for internal use by yourself, employees and agents within your organization within the United States and its territories. Curettage and electrodessication (C and E). Self-Administered Drug (SAD) Exclusion List articles list the CPT/HCPCS codes that are excluded from coverage under this category. Instructions for enabling "JavaScript" can be found here. The CPT code should reflect the knowledge, skill, time and effort that the provider invests in the excision of the lesion. (carcinoma in situ of skin), excludes basal and squamous cell in situ lesions D13.7 Benign neoplasm of endocrine pancreas Note: Effective 1/1/2021: Review this code to look for the following which were . CMS WILL NOT BE LIABLE FOR ANY CLAIMS ATTRIBUTABLE TO ANY ERRORS, OMISSIONS, OR OTHER INACCURACIES IN THE INFORMATION OR MATERIAL CONTAINED ON THIS PAGE. Reproduced with permission. All documentation must be maintained in the patient's medical record and made available to the contractor upon request. In no event shall CMS be liable for direct, indirect, special, incidental, or consequential You can use the Contents side panel to help navigate the various sections. . Copyright 2023. As a contributor you will produce quality content for the business of healthcare, taking the Knowledge Center forward with your knowhow and expertise. 625 0 obj <>/Filter/FlateDecode/ID[<300BF5E799812D49BBFB4D9A3883AA65>]/Index[604 32]/Info 603 0 R/Length 104/Prev 172627/Root 605 0 R/Size 636/Type/XRef/W[1 3 1]>>stream Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not Subscribe to Codify by AAPC and get the code details in a flash. 8 [QUOTE="thomas7331, post: 507729, member: 5404"] GOVERNMENT AND ITS EMPLOYEES ARE NOT LIABLE FOR ANY ERRORS, OMISSIONS, OR OTHER INACCURACIES IN THE INFORMATION, PRODUCT, OR PROCESSES You can collapse such groups by clicking on the group header to make navigation easier. The program covers drugs that are furnished "incident-to" a physician's service provided that the drugs are not "usually self-administered" by the patient. required field. For purpose of this exclusion, "the term 'usually' means more than 50 percent of the time for all Medicare beneficiaries who use the drug. Squamous cell carcinoma (80703; arises mostly in lower third of cervix; 90% of all cervical cancers; also called epidermoid carcinoma) Squamous carcinoma in situ with questionable stromal invasion (80762) If the "INDICATOR" is set to "2" these records were re -reviewed and over road the rules from ICD-O-3 code book. In no event shall CMS be liable for direct, indirect, special, incidental, or consequential damages arising out of the use of such information or material. apply equally to all claims. Since the morphology of the lesions can mimic that of other cutaneous disorders, Bowen's disease is often not recognized initially. recipient email address(es) you enter. The AMA does not directly or indirectly practice medicine or dispense medical services. Billable - D04.0 Carcinoma in situ of skin of lip Billable - D04.10 Carcinoma in situ of skin of unspecified eyelid, including canthus I have had this denial as well, sent appeal stating these are two separate lesions and unrelated conditions- appeals are still being upheld C44.52- Squamous cell carcinoma of skin of trunk You can collapse such groups by clicking on the group header to make navigation easier. All neoplasms are classified in this chapter, whether they are functionally active or not. Breast codes for ICD-10-CM include sex along with laterality. CPT codes, descriptions and other data only are copyright 2022 American Medical Association. C44.311 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. GOVERNMENT AND ITS EMPLOYEES ARE NOT LIABLE FOR ANY ERRORS, OMISSIONS, OR OTHER INACCURACIES IN THE INFORMATION, PRODUCT, OR PROCESSES Applications are available at the AMA Web site, http://www.ama-assn.org/go/cpt. presented in the material do not necessarily represent the views of the AHA. Billing and Coding articles typically include CPT/HCPCS procedure codes, ICD-10-CM diagnosis codes, as well as Bill Type, Revenue, and CPT/HCPCS Modifier codes. CMS believes that the Internet is The following ICD-10-CM codes support medical necessity and provide limited coverage for CPT codes: 11640, 11641, 11642, 11643, 11644, and 11646. can we bill dx M54.42 and M51.16 together? Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes. An official website of the United States government. 2016 (effective 10/1/2015): New code (first year of non . Chemical exposures, such as arsenic in drinking water, tar, or working with insecticides or herbicides. Also, you can decide how often you want to get updates. B5l2`4'l2_v n6M#~zx#d[mp1VXlu[1NWJu~@}Z~@R'h&\x$f$e" =ih9L|-U*|=LeXOs9"eY9j=IYRh{p "AYqn[sNxD!D>* Hqq0.DzXCX|P| VGi] kb$+%=IpzpTkk*. If you are experiencing any technical issues related to the search, selecting the 'OK' button to reset the search data should resolve your issues. Before sharing sensitive information, make sure you're on a federal government site. Organizations who contract with CMS acknowledge that they may have a commercial CDT license with the ADA, and that use of CDT codes as permitted herein for the administration of CMS programs does not extend to any other programs or services the organization may administer and royalties dues for the use of the CDT codes are governed by their commercial license. Signs and symptoms of SCCs include: Squamous cell carcinoma is most commonly seen in fair-skinned people who have spent extended time in the sun. Example 1: A patient returns to the dermatologist to discuss removal of his SCC on his lower lip. "JavaScript" disabled. The AMA is a third party beneficiary to this Agreement. _) Y New Term 8013/3 Combined large cell neuroendocrine carcinoma (C34. Primary malignant neoplasms overlapping site boundaries. Applicable Federal Acquisition Regulation Clauses (FARS)/Department of Defense Federal Acquisition Regulation supplement (DFARS) Restrictions Apply to Government Use. This common malignancy is primarily seen in older adults and most frequently occurs on sun-exposed skin. accuracy of any information contained in this material, nor was the AHA or any of its affiliates, involved in the Primary malignant neoplasms overlapping site boundaries. These materials contain Current Dental Terminology (CDTTM), copyright© 2022 American Dental Association (ADA). The size and location of the lesion must be included in the documentation. Local Coverage Articles are a type of educational document published by the Medicare Administrative Contractors (MACs). Alerts and Notices Synopsis Cutaneous squamous cell carcinoma in situ (SCCis), also known as Bowen disease, is defined histopathologically by malignant keratinocytes that involve the full thickness of the epidermis. Approximate Synonyms dx code of D04.4 from the ICD10 manual is description below. CDT is a trademark of the ADA. copied without the express written consent of the AHA. However, please note that once a group is collapsed, the browser Find function will not find codes in that group. copied without the express written consent of the AHA. If an entity wishes to utilize any AHA materials, please contact the AHA at 312‐893‐6816. About 90% of cases of head and neck cancer (cancer of the mouth, nasal cavity, nasopharynx, throat and associated structures) are due to SCC.. . q_r7ds1A"TTD`3i6`q@Jia$D/ %]/_ The AMA assumes no liability for data contained or not contained herein. Noninvasive can be used as a synonym for in situ, ICD-O-3 behavior code /2. CDT is a trademark of the ADA. To submit a comment or question to CMS, please use the Feedback/Ask a Question link available at the bottom Proper coding is C44.02Squamous cell carcinoma of skin of lip. Stage 0: tis: carcinoma in situ; n0: no regional lymph node metastasis; m0: no distant metastasis. Therefore, if a drug is self-administered by more than 50 percent of Medicare beneficiaries, the drug is excluded from coverage" and the MAC will make no payment for the drug. All documentation must be maintained in the patient's medical record and made available to the contractor upon request. CMS believes that the Internet is Get free rules, notes, crosswalks, synonyms, history for ICD-10 code C44.62. 0 The older a person, the longer sun exposure they have had, Overexposure or long-term exposure to X-rays. We are looking for thought leaders to contribute content to AAPCs Knowledge Center. Cutaneous squamous-cell carcinoma is the second most common skin cancer, accounting for over 1 million cases in the United States each year.. Thyroid []. Skin []. Please visit the. You shall not remove, alter, or obscure any ADA copyright notices or other proprietary rights notices included in the materials. Whether the site is primary, secondary, or carcinoma, Site on the skin (e.g., trunk, upper limb, or lower limb). The AMA does not directly or indirectly practice medicine or dispense medical services. End User Point and Click Amendment: C44.32- Squamous cell carcinoma of skin of other an unspecified parts of face In no event shall CMS be liable for direct, indirect, special, incidental, or consequential Cancer in situ, skin of scalp 7500 Security Boulevard, Baltimore, MD 21244. CMS and its products and services are However, ICD-10 codes specify the exact site on the skin along with the laterality (right or left). It begins in the squamous cells, which comprise most of the skins epidermis. Squamous cell carcinoma of the anus (C210) is reportable. The following ICD-10-CM codes support medical necessity and provide limited coverage for CPT codes: 11600, 11601, 11602, 11603, 11604, and 11606. This email will be sent from you to the 2. "Invasive" squamous cell carcinomas are the type that grow inward and may spread. The code lists in the article help explain which services (procedures) the related LCD applies to, the diagnosis codes for which the service is covered, or for which the service is not considered reasonable and necessary and therefore not covered. As the post above indicates, there is an Excludes1 note, but it is incorrect in stating that they may not be billed together. C44.42 Squamous cell carcinoma of skin of scalp and neck MACs are Medicare contractors that develop LCDs and Articles along with processing of Medicare claims. While every effort has been made to provide accurate and Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes. not endorsed by the AHA or any of its affiliates. ICD-10-CM Codes that Support Medical Necessity, ICD-10-CM Codes that DO NOT Support Medical Necessity, L33813 - Destruction of Malignant Skin Lesions, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), TRUNK, ARMS OR LEGS; LESION DIAMETER 0.5 CM OR LESS, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), TRUNK, ARMS OR LEGS; LESION DIAMETER 0.6 TO 1.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), TRUNK, ARMS OR LEGS; LESION DIAMETER 1.1 TO 2.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), TRUNK, ARMS OR LEGS; LESION DIAMETER 2.1 TO 3.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), TRUNK, ARMS OR LEGS; LESION DIAMETER 3.1 TO 4.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), TRUNK, ARMS OR LEGS; LESION DIAMETER OVER 4.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), SCALP, NECK, HANDS, FEET, GENITALIA; LESION DIAMETER 0.5 CM OR LESS, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), SCALP, NECK, HANDS, FEET, GENITALIA; LESION DIAMETER 0.6 TO 1.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), SCALP, NECK, HANDS, FEET, GENITALIA; LESION DIAMETER 1.1 TO 2.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), SCALP, NECK, HANDS, FEET, GENITALIA; LESION DIAMETER 2.1 TO 3.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), SCALP, NECK, HANDS, FEET, GENITALIA; LESION DIAMETER 3.1 TO 4.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), SCALP, NECK, HANDS, FEET, GENITALIA; LESION DIAMETER OVER 4.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), FACE, EARS, EYELIDS, NOSE, LIPS, MUCOUS MEMBRANE; LESION DIAMETER 0.5 CM OR LESS, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), FACE, EARS, EYELIDS, NOSE, LIPS, MUCOUS MEMBRANE; LESION DIAMETER 0.6 TO 1.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), FACE, EARS, EYELIDS, NOSE, LIPS, MUCOUS MEMBRANE; LESION DIAMETER 1.1 TO 2.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), FACE, EARS, EYELIDS, NOSE, LIPS, MUCOUS MEMBRANE; LESION DIAMETER 2.1 TO 3.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), FACE, EARS, EYELIDS, NOSE, LIPS, MUCOUS MEMBRANE; LESION DIAMETER 3.1 TO 4.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), FACE, EARS, EYELIDS, NOSE, LIPS, MUCOUS MEMBRANE; LESION DIAMETER OVER 4.0 CM, Malignant neoplasm of overlapping sites of palate, Malignant neoplasm of palate, unspecified, Malignant neoplasm of overlapping sites of unspecified parts of mouth, Malignant neoplasm of overlapping sites of other parts of mouth, Malignant melanoma of unspecified eyelid, including canthus, Malignant melanoma of right upper eyelid, including canthus, Malignant melanoma of right lower eyelid, including canthus, Malignant melanoma of left upper eyelid, including canthus, Malignant melanoma of left lower eyelid, including canthus, Malignant melanoma of unspecified ear and external auricular canal, Malignant melanoma of right ear and external auricular canal, Malignant melanoma of left ear and external auricular canal, Malignant melanoma of unspecified part of face, Malignant melanoma of other parts of face, Malignant melanoma of other part of trunk, Malignant melanoma of unspecified upper limb, including shoulder, Malignant melanoma of right upper limb, including shoulder, Malignant melanoma of left upper limb, including shoulder, Malignant melanoma of unspecified lower limb, including hip, Malignant melanoma of right lower limb, including hip, Malignant melanoma of left lower limb, including hip, Malignant melanoma of overlapping sites of skin, Merkel cell carcinoma of unspecified eyelid, including canthus, Merkel cell carcinoma of right upper eyelid, including canthus, Merkel cell carcinoma of right lower eyelid, including canthus, Merkel cell carcinoma of left upper eyelid, including canthus, Merkel cell carcinoma of left lower eyelid, including canthus, Merkel cell carcinoma of unspecified ear and external auricular canal, Merkel cell carcinoma of right ear and external auricular canal, Merkel cell carcinoma of left ear and external auricular canal, Merkel cell carcinoma of unspecified part of face, Merkel cell carcinoma of other parts of face, Merkel cell carcinoma of other part of trunk, Merkel cell carcinoma of unspecified upper limb, including shoulder, Merkel cell carcinoma of right upper limb, including shoulder, Merkel cell carcinoma of left upper limb, including shoulder, Merkel cell carcinoma of unspecified lower limb, including hip, Merkel cell carcinoma of right lower limb, including hip, Merkel cell carcinoma of left lower limb, including hip, Merkel cell carcinoma of overlapping sites, Other specified malignant neoplasm of skin of lip, Basal cell carcinoma of skin of right upper eyelid, including canthus, Basal cell carcinoma of skin of right lower eyelid, including canthus, Basal cell carcinoma of skin of left upper eyelid, including canthus, Basal cell carcinoma of skin of left lower eyelid, including canthus, Squamous cell carcinoma of skin of right upper eyelid, including canthus, Squamous cell carcinoma of skin of right lower eyelid, including canthus, Squamous cell carcinoma of skin of left upper eyelid, including canthus, Squamous cell carcinoma of skin of left lower eyelid, including canthus, Other specified malignant neoplasm of skin of right upper eyelid, including canthus, Other specified malignant neoplasm of skin of right lower eyelid, including canthus, Other specified malignant neoplasm of skin of left upper eyelid, including canthus, Other specified malignant neoplasm of skin of left lower eyelid, including canthus, Basal cell carcinoma of skin of right ear and external auricular canal, Basal cell carcinoma of skin of left ear and external auricular canal, Squamous cell carcinoma of skin of right ear and external auricular canal, Squamous cell carcinoma of skin of left ear and external auricular canal, Other specified malignant neoplasm of skin of right ear and external auricular canal, Other specified malignant neoplasm of skin of left ear and external auricular canal, Basal cell carcinoma of skin of other parts of face, Squamous cell carcinoma of skin of other parts of face, Other specified malignant neoplasm of skin of nose, Other specified malignant neoplasm of skin of other parts of face, Basal cell carcinoma of skin of scalp and neck, Squamous cell carcinoma of skin of scalp and neck, Other specified malignant neoplasm of skin of scalp and neck, Basal cell carcinoma of skin of other part of trunk, Squamous cell carcinoma of skin of breast, Squamous cell carcinoma of skin of other part of trunk, Other specified malignant neoplasm of anal skin, Other specified malignant neoplasm of skin of breast, Other specified malignant neoplasm of skin of other part of trunk, Basal cell carcinoma of skin of right upper limb, including shoulder, Basal cell carcinoma of skin of left upper limb, including shoulder, Squamous cell carcinoma of skin of right upper limb, including shoulder, Squamous cell carcinoma of skin of left upper limb, including shoulder, Other specified malignant neoplasm of skin of right upper limb, including shoulder, Other specified malignant neoplasm of skin of left upper limb, including shoulder, Basal cell carcinoma of skin of right lower limb, including hip, Basal cell carcinoma of skin of left lower limb, including hip, Squamous cell carcinoma of skin of right lower limb, including hip, Squamous cell carcinoma of skin of left lower limb, including hip, Other specified malignant neoplasm of skin of right lower limb, including hip, Other specified malignant neoplasm of skin of left lower limb, including hip, Basal cell carcinoma of overlapping sites of skin, Squamous cell carcinoma of overlapping sites of skin, Other specified malignant neoplasm of overlapping sites of skin, Malignant neoplasm of peripheral nerves of head, face and neck, Malignant neoplasm of peripheral nerves of unspecified upper limb, including shoulder, Malignant neoplasm of peripheral nerves of right upper limb, including shoulder, Malignant neoplasm of peripheral nerves of left upper limb, including shoulder, Malignant neoplasm of peripheral nerves of unspecified lower limb, including hip, Malignant neoplasm of peripheral nerves of right lower limb, including hip, Malignant neoplasm of peripheral nerves of left lower limb, including hip, Malignant neoplasm of peripheral nerves of thorax, Malignant neoplasm of peripheral nerves of abdomen, Malignant neoplasm of peripheral nerves of pelvis, Malignant neoplasm of peripheral nerves of trunk, unspecified, Malignant neoplasm of overlapping sites of peripheral nerves and autonomic nervous system, Malignant neoplasm of connective and soft tissue of head, face and neck, Malignant neoplasm of connective and soft tissue of unspecified upper limb, including shoulder, Malignant neoplasm of connective and soft tissue of right upper limb, including shoulder, Malignant neoplasm of connective and soft tissue of left upper limb, including shoulder, Malignant neoplasm of connective and soft tissue of unspecified lower limb, including hip, Malignant neoplasm of connective and soft tissue of right lower limb, including hip, Malignant neoplasm of connective and soft tissue of left lower limb, including hip, Malignant neoplasm of connective and soft tissue of thorax, Malignant neoplasm of connective and soft tissue of abdomen, Malignant neoplasm of connective and soft tissue of pelvis, Malignant neoplasm of connective and soft tissue of trunk, unspecified, Malignant neoplasm of overlapping sites of connective and soft tissue, Malignant neoplasm of head, face and neck, Malignant neoplasm of unspecified upper limb, Malignant neoplasm of unspecified lower limb, Malignant neoplasm of other specified ill-defined sites, Melanoma in situ of unspecified eyelid, including canthus, Melanoma in situ of right upper eyelid, including canthus, Melanoma in situ of right lower eyelid, including canthus, Melanoma in situ of left upper eyelid, including canthus, Melanoma in situ of left lower eyelid, including canthus, Melanoma in situ of unspecified ear and external auricular canal, Melanoma in situ of right ear and external auricular canal, Melanoma in situ of left ear and external auricular canal, Melanoma in situ of unspecified part of face, Melanoma in situ of breast (skin) (soft tissue), Melanoma in situ of unspecified upper limb, including shoulder, Melanoma in situ of right upper limb, including shoulder, Melanoma in situ of left upper limb, including shoulder, Melanoma in situ of unspecified lower limb, including hip, Melanoma in situ of right lower limb, including hip, Melanoma in situ of left lower limb, including hip, Carcinoma in situ of skin of unspecified eyelid, including canthus, Carcinoma in situ of skin of right upper eyelid, including canthus, Carcinoma in situ of skin of right lower eyelid, including canthus, Carcinoma in situ of skin of left upper eyelid, including canthus, Carcinoma in situ of skin of left lower eyelid, including canthus, Carcinoma in situ of skin of unspecified ear and external auricular canal, Carcinoma in situ of skin of right ear and external auricular canal, Carcinoma in situ of skin of left ear and external auricular canal, Carcinoma in situ of skin of unspecified part of face, Carcinoma in situ of skin of other parts of face, Carcinoma in situ of skin of scalp and neck, Carcinoma in situ of skin of unspecified upper limb, including shoulder, Carcinoma in situ of skin of right upper limb, including shoulder, Carcinoma in situ of skin of left upper limb, including shoulder, Carcinoma in situ of skin of unspecified lower limb, including hip, Carcinoma in situ of skin of right lower limb, including hip, Carcinoma in situ of skin of left lower limb, including hip, Some older versions have been archived.